Acquisition Overview - Patient Square Capital is acquiring Premier, a technology-powered healthcare improvement company, for a total deal value of $2.6 billion [1] - Premier's board has unanimously approved the acquisition, with shareholders set to receive $28.25 per share, representing a 23.8% premium over its 60-day volume-weighted average price [1] Company Insights - Premier's president and CEO, Michael Alkire, highlighted the company's growth since going public in 2013, emphasizing its supply chain expertise, technology, and advisory capabilities [2] - The transition to private ownership is expected to enhance Premier's financial flexibility and provide resources for advancing its product portfolio and innovation [2] Future Prospects - Neel Varshney, founding partner at Patient Square, expressed confidence in Premier's potential for growth in supply chain services, data and technology offerings, and consulting solutions [3] - The acquisition is subject to shareholder approval, regulatory clearances, and other closing conditions [3] Advisory Roles - Goldman Sachs and BofA Securities are serving as financial advisers to Premier, while Kirkland & Ellis is advising Patient Square on the acquisition [4]

MILWAUKEE , Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Premier (Nasdaq: PINC) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square Capital. ...

Market Overview - The three major U.S. stock indices opened lower, with the Dow Jones down 0.38%, the Nasdaq down 0.12%, and the S&P 500 down 0.22% [1] Company Highlights - Metsera, a developer of anti-obesity drugs, surged over 57% following reports that Pfizer is close to acquiring the company for $7.3 billion [1] - ASML rose over 3% as Morgan Stanley significantly raised its target price from €600 to €950 [1] - Snap experienced an increase of over 10% [1] - Premier, a healthcare company, saw its stock rise over 8% [1] - Harmony Gold gained over 4% [1] - Baidu's stock increased by over 3% [1]

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Premier, Inc. (NASDAQ: PINC) to an affiliate of Patient Square Capital for $28.25 in cash per share is fair to Premier shareholders. Halper Sadeh encourages Premier shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth. ...

Group 1 - Premier has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital [1] - The acquisition has been unanimously approved by Premier's board of directors [1] - Premier stockholders will receive $28.25 in cash per share as part of the acquisition [1]

Core Viewpoint - Premier, Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital, with stockholders set to receive $28.25 in cash per share, reflecting a 23.8% premium to the current share price [1] Company Summary - Premier, Inc. is described as a leading technology-driven health care improvement company [1] - The acquisition agreement has received unanimous approval from Premier's Board of Directors [1]

Group 1 - Nuclear Fuels Inc. has completed the arrangement where Premier American Uranium Inc. acquired all issued and outstanding common shares of Nuclear Fuels, resulting in Nuclear Fuels becoming a wholly owned subsidiary of Premier American Uranium [1][3] - As part of the arrangement, Nuclear Fuels shareholders received 0.33 of a common share of Premier American Uranium for each share of Nuclear Fuels held, totaling 32,521,748 shares issued by Premier American Uranium [2][4] - Nuclear Fuels Inc. will be delisted from the market at the close of trading on September 16, 2025 [2][4]

Core Insights - Premier, Inc. has announced a five-year group purchasing agreement with Premier Infusion and Healthcare Services, Inc. [1] Company Overview - Premier, Inc. is a technology-enabled healthcare performance improvement company [1] - Premier Infusion and HCS is a closed-door infusion pharmacy based in Torrance, California [1] Service Coverage - Premier Infusion and HCS serves all counties in California as well as Arizona, Colorado, Idaho, Illinois, Nevada, and Washington [1]

Core Viewpoint - Premier American Uranium Inc. has successfully completed the acquisition of Nuclear Fuels Inc., making it a wholly owned subsidiary, which enhances its exploration portfolio in the U.S. uranium sector [1][2][3]. Acquisition Details - The arrangement involved Premier American Uranium acquiring 100% of the outstanding common shares of Nuclear Fuels, with shareholders receiving 0.33 of a PUR share for each NF share held, totaling 32,521,748 PUR shares issued [2][4]. - The NF shares are expected to be delisted from the Canadian Securities Exchange on September 16, 2025, and Nuclear Fuels will apply to cease being a reporting issuer [4][6]. Strategic Implications - The acquisition strengthens Premier American Uranium's position in the Powder River uranium district, joining major landholders like Cameco Corporation and Energy Fuels Inc. [3][10]. - The company aims to consolidate, explore, and develop uranium projects across the U.S., focusing on enhancing domestic energy security and transitioning to clean energy [10][11]. Management Changes - Following the acquisition, the board of directors of Premier American Uranium has expanded to seven members, incorporating individuals from Nuclear Fuels, while the senior management team remains unchanged [5][6]. Financial Advisory - Haywood Securities Inc. served as the financial advisor for the arrangement, receiving 138,942 PUR shares as part of their compensation [9].

Core Insights - ReBound Returns has been named a Premier Partner of Shopify, enhancing its position as a leader in returns management [1] - The partnership aims to provide Shopify merchants with a seamless, enterprise-grade returns solution [1] - This collaboration is expected to help brands streamline operations, reduce costs, elevate customer satisfaction, and improve customer retention at scale [1]